How Analysts Changed Views on BioMarin After Earnings

Health and Healthcare

Published: February 28, 2016 10:45 am

Last Updated: January 13, 2020 12:36 pm

BioMarin Pharmaceuticals Inc. (NASDAQ: BMRN) reported its fourth-quarter financial results after the markets closed Thursday. Investors really took to this stock and there was a favorable jump after the report. However, analysts took a slightly different perspective and cut their price targets.

The company said it had $0.40 in earnings per share (EPS) on $227.9 million in revenue, which compared to consensus estimates from Thomson Reuters of $0.99 in EPS on revenue of $224.38 million. The same period from last year had a net loss of $0.47 per share on $230.85 million in revenue.

In terms of guidance for 2016, the company expects to have a non-GAP net loss of in the range of $75 million to $100 million, as well as total revenues in the range of $1.05 billion to $1.10 million. The consensus estimates for the full year call for a net loss of $2.27 per share on $1.15 billion in revenue.

A few analysts weighed in on BioMarin after earnings:

JPMorgan has an Overweight rating and lowered its price target to $117 from $121.
Piper Jaffray has an Overweight rating and lowered its price target to $107 from $118.
Jefferies has a Buy rating and lowered its price target from $132 to $120.
RBC has an Outperform rating and lowered its price target to $125 from $155.
Goldman Sachs lowered its price target to $129 from $131.

ALSO READ: Top 4 Biopharma Movers of the Past Week

So far in 2016, BioMarin has underperformed the broad markets, with the stock down 27%. Over the past 52 weeks, the stock fell 28%.

Shares of BioMarin ended last week at $80.14, with a consensus analyst price target of $127.84 and a 52-week trading range of $62.12 to $151.75.

Take Charge of Your Retirement In Just A Few Minutes (Sponsor)

Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance—and SmartAsset’s made it easier than ever for you to connect with a vetted financial advisor.

Here’s how it works:

Answer a Few Simple Questions. Tell us a bit about your goals and preferences—it only takes a few minutes!
Get Matched with Vetted Advisors Our smart tool matches you with up to three pre-screened, vetted advisors who serve your area and are held to a fiduciary standard to act in your best interests. Click here to begin
Choose Your Fit Review their profiles, schedule an introductory call (or meet in person), and select the advisor who feel is right for you.

Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!